Ginkgo Bioworks Holdings Inc (DNA)
0.8705
+0.03
(+3.29%)
USD |
NYSE |
Apr 23, 16:00
0.8888
+0.02
(+2.10%)
Pre-Market: 06:43
Ginkgo Bioworks Holdings Shareholders Equity (Quarterly): 1.097B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.097B |
| September 30, 2023 | 1.253B |
| June 30, 2023 | 1.504B |
| March 31, 2023 | 1.608B |
| December 31, 2022 | 1.736B |
| September 30, 2022 | 1.435B |
| Date | Value |
|---|---|
| June 30, 2022 | 1.535B |
| March 31, 2022 | 1.581B |
| December 31, 2021 | 1.505B |
| September 30, 2021 | 1.552B |
| December 31, 2020 | 461.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
461.38M
Minimum
Dec 2020
1.736B
Maximum
Dec 2022
1.388B
Average
1.505B
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Agenus Inc | -160.33M |
| Teladoc Health Inc | 2.326B |
| Sarepta Therapeutics Inc | 859.34M |
| Ultragenyx Pharmaceutical Inc | 275.41M |
| Apellis Pharmaceuticals Inc | 194.52M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.665B |
| Total Liabilities (Quarterly) | 568.19M |
| Current Ratio | 6.113 |